TrialNeurology2024

Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial.

Douglas L Arnold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.